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Summary 
1 2
We have previously demonstrated that lung 
lesions decrease average daily gain in lambs.  
We have also observed fall born lambs have a 
lower prevalence of lung lesions than spring 
born lambs.  The different prevalence in lung 
lesions between spring and fall born lambs 
suggests that lung lesions can be prevented.  
Mannheimia (Pasteurella) haemolytica and/or 
Pasteurella multocida are present in lambs with 
moderate or severe lung lesions, but not in 
lambs with normal lung tissue.  In serial 
slaughter studies, we observed lung lesions 
formed post-weaning.  Therefore, we designed 
two studies to test possible intervention 
strategies to reduce the prevalence or severity 
of lung lesions.  In the first study, lambs were 
vaccinated against Mannheimia (Pasteurella) 
Haemolytica and Pasteurella Multocida at 4 and 
2 weeks prior to weaning, at weaning, and 2 and 
6 weeks after weaning (a minimum of 21 days 
before slaughter).   
 
In the second study, lambs were fed 
chlorotetracycline for two weeks following 
weaning.  All lambs had feed available ad 
libitum.  At slaughter, lamb lungs were examined 
for lung lesions.  Lambs were determined to 
have moderate lung lesions if greater than 5% 
but less than or equal to 50% of a lobe was 
consolidated and severe lung lesions if over 
50% of any lobe was consolidated.  Vaccination 
did not alter the prevalence of lung lesions (82% 
vs. 84% prevalence of lung lesions in vaccinated 
vs. not vaccinated lambs).  Nor was the 
prevalence of severe lung lesions altered (63% 
prevalence of severe lung lesions in vaccinated 
and not vaccinated lambs).  Feeding 
chlorotetracyline did not alter the prevalence of 
lung lesions (79% vs. 84% prevalence of lung 
lesions in chlorotetracycline fed vs. control diet) 
or the prevalence of severe lung lesions (58% 
vs. 61% prevalence of severe lung lesions in 
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chlorotetracycline fed vs. control diet.  Lambs 
with severe lung lesions had lower average daily 
gain over the entire feeding period than lambs 
with normal lungs or moderate lung lesions (0.55 
± 0.02 lbs/day vs. 0.66 ± 0.02 lbs/day or 0.64 ± 
0.02 lbs/day, respectively.  Although neither 
vaccination nor feeding chlorotetracycline 
reduced the prevalence or severity of lung 
lesions, these results confirm that lung lesions 
negatively impact sheep production by reducing 
average daily gain of lambs.   
 
Introduction 
 
Clinical respiratory disease has long been 
acknowledged to have negative effects on lamb 
production, but subclinical respiratory disease 
has only recently become a concern.  
Subclinical respiratory disease in lambs can be 
identified by moderate (5-50% of any lobe) or 
severe (>50% of any lobe) consolidation of the 
lungs at slaughter.  We have observed that 
although only 8% of spring born lambs at South 
Dakota State University (SDSU) required 
individual treatment for respiratory disease, 38% 
(34 of 89) of the lambs had severe lung lesions, 
and 64% (57 of 89) of the lambs had either 
moderate or severe lung lesions (Daniel et al., 
2006).  Post weaning to finish growth 
performance was 0.07 pounds per day lower for 
those lambs diagnosed with severe lesions than 
moderate lesion or normal lungs (Daniel et al., 
2006).  Goodwin et al. also observed reduced 
daily weight gain during the month prior to 
slaughter in New Zealand lambs with greater 
than 20% of the lung surface area affected by 
lesions (2001).  However, in fall born lambs at 
SDSU only 7% (7 of 108) of the lambs had 
severe lung lesions and 29% (31 of 108) had 
either moderate or severe lung lesions (Daniel et 
al., 2006).  The different prevalence in lung 
lesions between spring and fall born lambs 
suggests that lung lesions can be prevented.   
 
Mannheimia (Pasteurella) haemolytica and/or 
Pasteurella multocida are present in lambs with 
moderate or severe lung lesions, but not in 
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lambs with normal lung tissue (Daniel et al., 
2006).  Mannheimia haemolytica and/or 
Pasteurella multocida are pathogens known to 
be capable of producing consolidative lesions 
and mild illness without clinical signs (Sharp et 
al., 1978).  Our findings suggest that these 
common respiratory pathogens are present in 
lung lesions, and present a possible intervention 
target for reducing the prevalence of lung 
lesions. 
 
In serial slaughter studies, we observed lung 
lesions formed post-weaning (Daniel et al., 
2006).  Therefore, we designed two studies to 
test possible intervention strategies to reduce 
the prevalence and severity of lung lesions.  The 
objective of the first study was to determine if 
vaccination against Mannheimia (Pasteurella) 
haemolytica and Pasteurella multocida would 
reduce the incidence of lung lesions at 
slaughter.  The objective of the second study 
was to determine if feeding low levels of 
chlorotetracycline at weaning would reduce the 
prevalence of lung lesions at slaughter. 
 
Materials and Methods 
 
Experiment 1:  In spring of 2004, crossbred 
wethers (n= 76) born at the SDSU Sheep Unit 
were randomly assigned to either vaccinated or 
non-vaccinated groups.  Vaccinated lambs 
received with an avirulent Pasteurella 
Haemolytica-Multocida live culture (Once PMH 
serial no. 07973836 and 07973838, Intervet, 
Millsboro, Delaware) and a Pasteurella 
Haemolytica-Multocida bacterin (Lamb 
Pneumonia Vaccine serial no. 939B, Colorado 
Serum Company, Denver, Colorado) at 4 and 2 
weeks prior to weaning, at weaning, and 2 and 6 
weeks after weaning (a minimum of 21 days 
before slaughter).  At weaning, lambs were 
assigned to one of six pens depending upon 
vaccination treatment.   All pens were in the 
same barn, and lambs were prevented from 
having nose to nose contact with lambs in other 
pens.  Lambs had feed available ad libitum.  At 
slaughter, lamb lungs were examined for 
lesions. 
 
Experiment 2:  At weaning in the spring of 2005, 
crossbred wethers (n = 82) born at the SDSU 
Sheep Unit were randomly assigned to one of 
six pens.   All pens were in the same barn, and 
lambs were prevented from having nose to nose 
contact with lambs in other pens.  Pens were fed 
the control diet or control diet plus 50 g/ton 
chlorotetracycline for two weeks following 
weaning.  After two weeks, all pens were fed the 
same diet.  Lambs had feed available ad libitum.  
Lambs were weighted every 28 days, and were 
slaughtered when two-thirds of the lambs were 
54 kg or greater live weight.  At slaughter, lamb 
lungs were examined for lesions.  Carcass data 
(fat thickness at 12th rib, ribeye area, and body 
wall thickness) were collected approximately 24 
hrs after slaughter.   
 
Lung lesion scoring:  Lambs were determined to 
have severe lung lesions if over 50% of any lobe 
was consolidated.  Lambs were considered to 
have moderate lung lesions if greater than 5% 
but less than or equal to 50% of a lobe was 
consolidated.  Lambs were considered to have 
normal lungs if not more than 5% of any lobe 
was consolidated.  Lungs were also examined 
for the presence of active abscesses or pleural 
adhesions.   
 
Statistics:  Effect of treatment on prevalence and 
severity of lung lesions were tested by Chi-
square comparison.  Data were also tested for 
effect of chlorotetracycline and lung lesion 
prevalence and severity on 28 day weights, 
average daily gain, and hot carcass weight using 
ANOVA and effect of chlorotetracycline and lung 
lesion prevalence and severity on carcass traits 
using ANOVA with hot carcass weight as a co-
variant.  All data were analyzed using SAS 
software (SAS Inc., Cary, NC). 
 
Results and Discussion 
 
Experiment 1: Vaccination did not alter the 
prevalence of lung lesions (82% vs 84% 
prevalence of lung lesions in vaccinated vs not 
vaccinated lambs; P = 0.76); nor was the 
prevalence of severe lung lesions altered (63% 
prevalence of severe lung lesions in vaccinated 
and not vaccinated lambs; P = 0.80). 
 
Experiment 2:  Treatment did not alter the 
prevalence of lung lesions (79% vs. 84% 
prevalence of lung lesions in chlorotetracycline 
fed vs. control diet; P = 0.55) or the prevalence 
of severe lung lesions (58% vs. 61% prevalence 
of severe lung lesions in chlorotetracycline fed 
vs. control diet; P = 0.75).  Feeding of 
chlorotetracycline did not alter any growth or 
carcass traits relative to control fed lambs (P > 
0.05).  The presence of lung lesions or the 
severity of lung lesion did not impact any 
carcass traits examined (P > 0.05).  Lambs with 
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severe lung lesions were heavier than lambs 
with normal lungs after the first 28 days after 
weaning (103.6 ± 2.2 lbs vs. 90.8 ± 6.2 lbs, 
respectively; P = 0.01), but lambs with severe 
lung lesions had lower average daily gain over 
the entire feeding period than lambs with normal 
lungs or moderate lung lesions (0.55 ± 0.02 
lbs/day vs. 0.66 ± 0.02 lbs/day or 0.64 ± 0.02 
lbs/day, respectively; P > 0.02).   
 
Based on these results, it does not appear 
vaccination against Mannheimia (Pasteurella) 
haemolytica and Pasteurella multocida and 
feeding targeted levels of chlorotetracycline 
following weaning prevent the formation or 
reduce the severity of lung lesions.  However, 
these results do confirm that severe lung lesions 
reduce average daily gain in lambs.  These 
results also suggest that larger or faster growing 
after weaning may be at greater risk of 
developing severe lung lesions.   
 
Implications 
 
Lung lesions negatively impact sheep production 
by reducing average daily gain of lambs.  
Development of effective intervention strategies 
to reduce the prevalence or severity of lung 
lesions would allow for increased average daily 
gain of lambs. 
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